Evidence-Based Heart Failure Management: A Practical Guide for Hospitalists

Area of Science:

• Cardiology
• Internal Medicine

Background:

• Heart failure (HF) presents a significant global health challenge with high morbidity and mortality.
• Accurate classification of HF based on left ventricular ejection fraction (LVEF) is crucial for effective diagnosis and management.
• Current classifications include heart failure with reduced ejection fraction (HFrEF), heart failure with preserved ejection fraction (HFpEF), heart failure with mildly reduced ejection fraction (HFmrEF), and heart failure with improved ejection fraction (HFimpEF).

Purpose of the Study:

• To provide a comprehensive overview of current treatment strategies for different classifications of heart failure.
• To highlight the importance of rapid pharmacologic therapy initiation in optimizing patient outcomes.
• To address the challenges in managing HFmrEF and HFimpEF due to their heterogeneous nature.

Main Methods:

• This narrative review synthesizes current evidence and guidelines.
• It focuses on treatment strategies tailored to distinct HF classifications.
• Emphasis is placed on the role of early and simultaneous initiation of key pharmacologic therapies.

Main Results:

• While HFrEF management has seen therapeutic advancements, HFmrEF and HFimpEF require optimized, individualized treatment approaches.
• Emerging strategies advocate for the prompt and concurrent introduction of foundational pharmacologic therapies across all HF subtypes.
• Personalized treatment plans, informed by patient specifics and emerging data, are vital.

Conclusions:

• Optimizing heart failure care necessitates a strategic approach to pharmacologic therapy initiation.
• Tailoring treatments to specific HF classifications, particularly HFmrEF and HFimpEF, is essential for maximizing clinical benefits.
• Rapid initiation of evidence-based therapies offers a promising avenue for improving patient outcomes in heart failure.